caselaw.findlaw.com/us-3rd-circuit/1313639.html

ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb .... Third, he contends defendants knowingly conspired with Medco and others to violate ...

casetext.com/case/united-states-v-astrazeneca-biopharmaceuticals-inc

Apr 17, 2017 ... Astrazeneca Biopharmaceuticals, Inc. ... PLC; Astrazeneca, LP; and Astrazeneca Pharmaceuticals, LP (together, ... AstraZeneca, et al., No.

www.justice.gov/archive/opa/pr/2003/June/03_civ_371.htm

Jun 20, 2003 ... ASTRAZENECA PHARMACEUTICALS LP PLEADS GUILTY ... physicians' practices, and others to purchase Zoladex, AstraZeneca offered and ... (v) AstraZeneca misreported and underpaid its Medicaid rebates for Zoladex ...

www.bloomberg.com/news/articles/2018-08-07/astrazeneca-to-pay-110-million-to-settle-texas-drug-suits-jkk6v647

Aug 7, 2018 ... AstraZeneca Plc agreed to pay $110 million to settle a Texas claim alleging that the ... by fraudulently marketing two medications, according to the state's attorney general office. ... The case is the State of Texas v. AstraZeneca LP, No. ... Trademarks Privacy Policy ©2019 Bloomberg L.P. All Rights Reserved.